Spectrum Pharmaceuticals Inc
SPPI
SPPI was delisted on the 31st of July, 2023.
101 hedge funds and large institutions have $92.5M invested in Spectrum Pharmaceuticals Inc in 2022 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 17 increasing their positions, 47 reducing their positions, and 56 closing their positions.
414% more call options, than puts
Call options by funds: $432K | Put options by funds: $84K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
26% less capital invested
Capital invested by funds: $125M → $92.5M (-$32.3M)
29% less funds holding
Funds holding: 142 → 101 (-41)
64% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 47
73% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 56
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$6.85M |
| 2 |
D.E. Shaw & Co
New York
|
+$6.43M |
| 3 |
Renaissance Technologies
New York
|
+$528K |
| 4 |
CM
CM Management
Gulf Breeze,
Florida
|
+$414K |
| 5 |
SIG
Sargent Investment Group
Bethesda,
Maryland
|
+$368K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$13.3M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$6.28M |
| 3 |
Goldman Sachs
New York
|
-$2.46M |
| 4 |
Millennium Management
New York
|
-$2.05M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.41M |
SPPI Hedge Fund Activity: Q1 2022 in Review
101 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q1 2022, worth a combined $92.5M — down 26% from $125M a quarter earlier.
Sellers outnumbered buyers: 56 funds closed out of SPPI and 15 opened new positions — a net loss of 41 holders — while 47 trimmed existing stakes and 17 added.
The largest buyer was Armistice Capital, adding an estimated $6.85M. The largest seller was BlackRock, cutting an estimated $13.3M.
- 101 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q1 2022, down from 142 in Q4 2021.
- Funds reported $92.5M of Spectrum Pharmaceuticals Inc stock for Q1 2022, down 26% quarter-over-quarter.
- 15 funds opened new Spectrum Pharmaceuticals Inc positions in Q1 2022 and 56 closed out, a net change of -41 holders.
- The largest Spectrum Pharmaceuticals Inc buyer in Q1 2022 was Armistice Capital, an estimated $6.85M added.
- The largest Spectrum Pharmaceuticals Inc seller in Q1 2022 was BlackRock, an estimated $13.3M sold.
Based on aggregated 13F filings for Q1 2022.